当前位置:首页 - 行情中心 - 派林生物(000403) - 财务分析

派林生物

(000403)

  

流通市值:163.21亿  总市值:164.89亿
流通股本:9.41亿   总股本:9.50亿

派林生物(000403)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润2.36亿元,每股收益0.25元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益789754.07万元,未分配利润225364.86万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产908129.61万元,负债118375.54万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入986,481,770.22374,649,641.982,654,684,638.931,890,265,336.27
营业总成本711,561,568.4276,480,817.31,815,728,401.841,279,639,389.94
其他经营收益
营业利润285,726,732.32109,867,387.81880,313,029.04638,752,175.75
利润总额268,930,121.96103,362,342.57852,778,057.65619,546,468.66
净利润235,916,844.5588,939,547.68745,042,150.36542,758,460.07
每股收益
其他综合收益-2,537.11-707.317,688.42-5,639.91
综合收益总额235,914,307.4488,938,840.37745,049,838.78542,752,820.16
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计3,320,695,525.693,469,649,834.083,578,948,533.753,542,327,499.32
非流动资产:
非流动资产合计5,760,600,5975,727,051,004.775,667,320,831.515,510,888,803.65
资产总计9,081,296,122.699,196,700,838.859,246,269,365.269,053,216,302.97
流动负债:
流动负债合计904,037,502.46827,866,779.33956,971,752.28871,456,614.84
非流动负债:
非流动负债合计279,717,896.99362,392,583.8371,794,977.63356,932,834.4
负债合计1,183,755,399.451,190,259,363.131,328,766,729.911,228,389,449.24
所有者权益(或股东权益):
归属于母公司股东权益合计7,904,564,897.898,013,739,259.897,924,650,751.557,831,710,847.17
股东权益合计7,897,540,723.248,006,441,475.727,917,502,635.357,824,826,853.73
负债和股东权益合计9,081,296,122.699,196,700,838.859,246,269,365.269,053,216,302.97
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计986,437,123.76504,109,212.862,548,993,766.251,898,641,784.43
经营活动现金流出小计1,179,101,021.55619,948,561.152,227,203,359.981,671,107,587.89
经营活动产生的现金流量净额-192,663,897.79-115,839,348.29321,790,406.27227,534,196.54
投资活动产生的现金流量:
投资活动现金流入小计700,121,187.6157,629,268.491,910,661,561.311,004,387,646.63
投资活动现金流出小计1,038,057,408.07604,346,822.662,246,597,592.071,845,936,861.43
投资活动产生的现金流量净额-337,936,220.46-546,717,554.17-335,936,030.76-841,549,214.8
筹资活动产生的现金流量:
筹资活动现金流入小计258,151,722.36120,293,204.46586,078,943.6366,326,135.38
筹资活动现金流出小计491,747,782.81112,173,983.75679,823,658.23426,976,688.04
筹资活动产生的现金流量净额-233,596,060.458,119,220.71-93,744,714.63-60,650,552.66
汇率变动对现金及现金等价物的影响-8,285.78-2,924.08-28,116.37-23,319.15
现金及现金等价物净增加额-764,204,464.48-654,440,605.83-107,918,455.49-674,688,890.07
期末现金及现金等价物余额556,156,090.13665,919,948.781,320,360,554.61753,590,120.03
补充资料:
现金及现金等价物的净增加额-764,204,464.48--107,918,455.49-
最新报告期:2025-09-05
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中信证券陈竹,王凯旋,韩世通0.901.121.232025-09-05
东方证券伍云飞,赵博宇0.871.051.252025-09-02
华源证券刘闯,李强0.770.860.962025-08-28
野村东方国际证券孔令岩0.931.071.222025-08-27
TOP↑